Your browser doesn't support javascript.
loading
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Bellini, Angela; Pötschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clément, Nathalie; Combaret, Valérie; Font de Mora, Jaime; George, Sally L; Jiménez, Irene; Jeison, Marta; Marques, Barbara; Martinsson, Tommy; Mazzocco, Katia; Morini, Martina; Mühlethaler-Mottet, Annick; Noguera, Rosa; Pierron, Gaelle; Rossing, Maria; Taschner-Mandl, Sabine; Van Roy, Nadine; Vicha, Ales; Chesler, Louis; Balwierz, Walentyna; Castel, Victoria; Elliott, Martin; Kogner, Per; Laureys, Geneviève; Luksch, Roberto; Malis, Josef; Popovic-Beck, Maja; Ash, Shifra; Delattre, Olivier; Valteau-Couanet, Dominique; Tweddle, Deborah A; Ladenstein, Ruth; Schleiermacher, Gudrun.
Affiliation
  • Bellini A; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.
  • Pötschger U; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
  • Bernard V; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
  • Lapouble E; Department for Studies and Statistics and Integrated Research, Vienna, Austria.
  • Baulande S; St Anna Children's Cancer Research Institute, Vienna, Austria.
  • Ambros PF; Institut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie, Paris, France.
  • Auger N; Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France.
  • Beiske K; Institut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie, Paris, France.
  • Bernkopf M; St Anna Children's Cancer Research Institute, Vienna, Austria.
  • Betts DR; Service de Génétique des tumeurs; Institut Gustave Roussy, Villejuif, France.
  • Bhalshankar J; Department of Pathology, Oslo University Hospital, and Medical Faculty, University of Oslo, Oslo, Norway.
  • Bown N; St Anna Children's Cancer Research Institute, Vienna, Austria.
  • de Preter K; Department of Clinical Genetics, Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Clément N; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.
  • Combaret V; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
  • Font de Mora J; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
  • George SL; Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Jiménez I; Ghent University, Ghent, Belgium.
  • Jeison M; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.
  • Marques B; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
  • Martinsson T; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
  • Mazzocco K; Translational Research Laboratory, Centre Léon Bérard, Lyon, France.
  • Morini M; Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Mühlethaler-Mottet A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Noguera R; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.
  • Pierron G; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
  • Rossing M; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
  • Taschner-Mandl S; Schneider Children's Medical Center of Israel, Tel Aviv University, Tel Aviv, Israel.
  • Van Roy N; Departamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
  • Vicha A; Sahlgrenska University Hospital, Göteborg, Sweden.
  • Chesler L; Department of Pathology, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Balwierz W; Laboratory of Molecular Biology, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Castel V; Pediatric Hematology-Oncology Research Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Elliott M; Department of Pathology, Medical School, University of Valencia-Incliva Health Research Institute/CIBERONC, Madrid, Spain.
  • Kogner P; Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France.
  • Laureys G; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Luksch R; St Anna Children's Cancer Research Institute, Vienna, Austria.
  • Malis J; Ghent University, Ghent, Belgium.
  • Popovic-Beck M; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Ash S; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, Sutton, United Kingdom.
  • Delattre O; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  • Valteau-Couanet D; Clinical and Translational Oncology Research Group, Health Research Institute La Fe, Valencia, Spain.
  • Tweddle DA; Leeds Children's Hospital, Leeds General Infirmary, Leeds, United Kingdom.
  • Ladenstein R; Karolinska University Hospital, Stockholm, Sweden.
  • Schleiermacher G; Department of Paediatric Haematology and Oncology, Princess Elisabeth Children's Hospital, Ghent University Hospital, Ghent, Belgium.
J Clin Oncol ; 39(30): 3377-3390, 2021 10 20.
Article in En | MEDLINE | ID: mdl-34115544

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Amplification / Mutation Rate / Anaplastic Lymphoma Kinase / Neuroblastoma Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Amplification / Mutation Rate / Anaplastic Lymphoma Kinase / Neuroblastoma Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: France Country of publication: United States